Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Cavco Industries
CVCO
$4.21B
| $2.78M | ﹤0.01% |
11,736
-1,718
| -13% | -$413K |
|
|
XHR
2252
Xenia Hotels & Resorts
XHR
$1.89B
| $2.78M | ﹤0.01% |
156,534
-33,729
| -18% | -$591K |
|
2253
Encore Capital Group
ECPG
$2.06B
| $2.77M | ﹤0.01% |
56,264
+23,399
| +71% | +$1.11M |
|
2254
Hess Midstream
HESM
$5.23B
| $2.77M | ﹤0.01% |
98,196
+25,910
| +36% | +$657K |
|
|
DCPH
2255
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.77M | ﹤0.01% |
81,508
-35,015
| -30% | -$1.12M |
|
|
KAHC
2256
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
| $2.76M | ﹤0.01% |
283,052
+190,277
| +205% | +$1.85M |
|
|
OKLO
2257
Oklo
OKLO
$7.17B
| $2.76M | ﹤0.01% |
+280,931
| New | +$2.77M |
|
2258
Diamondrock Hospitality Co
DRH
$2.74B
| $2.76M | ﹤0.01% |
291,793
-1,494,742
| -84% | -$13.4M |
|
2259
CALL
GoDaddy
GDDY
$11.7B
| $2.75M | ﹤0.01% |
+39,500
| New | +$3.06M |
|
2260
Korn Ferry
KFY
$4.21B
| $2.75M | ﹤0.01% |
38,031
-4,263
| -10% | -$297K |
|
2261
Cogent Communications
CCOI
$663M
| $2.75M | ﹤0.01% |
38,827
-31,775
| -45% | -$2.36M |
|
2262
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.6B
| $2.75M | ﹤0.01% |
11,632
-7,145
| -38% | -$1.73M |
|
2263
CALL
Phreesia
PHR
$698M
| $2.75M | ﹤0.01% |
+44,500
| New | +$2.97M |
|
2264
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.71B
| $2.74M | ﹤0.01% |
16,520
-8,470
| -34% | -$1.45M |
|
2265
Resideo Technologies
REZI
$5.49B
| $2.74M | ﹤0.01% |
110,610
-5,369
| -5% | -$156K |
|
|
NVTA
2266
PUT
DELISTED
Invitae Corporation
NVTA
| $2.74M | ﹤0.01% |
+96,300
| New | +$2.82M |
|
2267
Century Communities
CCS
$1.96B
| $2.74M | ﹤0.01% |
44,541
-9,132
| -17% | -$605K |
|
2268
Doximity
DOCS
$3.89B
| $2.74M | ﹤0.01% |
33,916
+30,083
| +785% | +$2.2M |
|
|
FLG
2269
Flagstar Bank National Association
FLG
$5.93B
| $2.73M | ﹤0.01% |
70,846
-113,246
| -62% | -$4.11M |
|
|
AQUA
2270
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.73M | ﹤0.01% |
72,809
-12,432
| -15% | -$449K |
|
2271
Coherent
COHR
$56.4B
| $2.73M | ﹤0.01% |
46,012
-182,948
| -80% | -$11.9M |
|
|
RETA
2272
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.73M | ﹤0.01% |
27,146
+8,403
| +45% | +$985K |
|
2273
Applied Industrial Technologies
AIT
$13B
| $2.73M | ﹤0.01% |
30,234
-700
| -2% | -$61.6K |
|
|
KRTX
2274
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.72M | ﹤0.01% |
22,268
-12,212
| -35% | -$1.41M |
|
2275
Albertsons Companies
ACI
$5.58B
| $2.72M | ﹤0.01% |
87,330
+8,281
| +10% | +$218K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.